Zydus Lifesciences Limited — Salmeterol Exporter Profile
Indian Pharmaceutical Exporter · #4 for Salmeterol · $1.1M export value · DGFT Verified
Zydus Lifesciences Limited is the #4 Indian exporter of Salmeterol with $1.1M in export value and 64 verified shipments. Zydus Lifesciences Limited holds a 1.5% market share in Salmeterol exports across 5 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Salmeterol Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Salmeterol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $596.4K | 35 | 55.3% |
| VIETNAM, DEMOCRATIC REP. OF | $184.0K | 9 | 17.1% |
| VIETNAM | $98.0K | 7 | 9.1% |
| SRI LANKA | $73.5K | 3 | 6.8% |
| KENYA | $64.7K | 4 | 6.0% |
| VIETNAM DEMOCRATIC REP OF | $28.9K | 3 | 2.7% |
| GUYANA | $22.7K | 2 | 2.1% |
| VIETNAM DEMOCRATIC REP. OF | $10.7K | 1 | 1.0% |
Zydus Lifesciences Limited exports Salmeterol to 8 countries. The largest destination is PHILIPPINES accounting for 55.3% of Zydus Lifesciences Limited's Salmeterol shipments, followed by VIETNAM, DEMOCRATIC REP. OF (17.1%) and VIETNAM (9.1%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Salmeterol from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ZYDUS HEALTHCARE PHILIPPINES INC. | PHILIPPINES | $468.5K | 29 |
| HAPHARCO J.S.C. BRANCH | VIETNAM, DEMOCRATIC REP. OF | $221.5K | 12 |
| ZYDUS HEALTHCARE PHILIPPINES INC | PHILIPPINES | $91.9K | 4 |
| STATE PHARMACEUTICALS | SRI LANKA | $73.5K | 3 |
| HAPHARCO J S C BRANCH | VIETNAM | $54.3K | 4 |
| ABACUS PHARMA (AFRICA) LTD | KENYA | $51.7K | 3 |
| HAPHARCO J.S.C. BRANCH. | VIETNAM | $36.7K | 3 |
| ZYDUS HEALTHCARE PHILIPPINES INC., | PHILIPPINES | $36.1K | 2 |
| NEW GPC INC. | GUYANA | $22.7K | 2 |
| ABACUS PHARMA AFRICA LTD | KENYA | $13.0K | 1 |
Zydus Lifesciences Limited supplies Salmeterol to 11 buyers globally. The largest buyer is ZYDUS HEALTHCARE PHILIPPINES INC. (PHILIPPINES), followed by HAPHARCO J.S.C. BRANCH (VIETNAM, DEMOCRATIC REP. OF) and ZYDUS HEALTHCARE PHILIPPINES INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Salmeterol Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $68.9M worth of Salmeterol through 7,006 shipments from 148 suppliers to 90 countries, serving 370 buyers globally. Zydus Lifesciences Limited contributes $1.1M to this total, accounting for 1.5% of India's Salmeterol exports. Zydus Lifesciences Limited ships Salmeterol to 8 countries through 11 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Salmeterol Exports?
Zydus Lifesciences Limited's average Salmeterol shipment value is $17.1K per consignment, based on 64 shipments totaling $1.1M. The largest destination is PHILIPPINES (55.3% of Zydus Lifesciences Limited's Salmeterol exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Salmeterol Exporters?
Zydus Lifesciences Limited ranks #4 among 148 Indian Salmeterol exporters with a 1.5% market share. The top 3 exporters are CIPLA LIMITED ($55.7M), HETERO LABS LIMITED ($6.4M), MEDISPRAY LABORATORIES PRIVATE LIMITED ($1.1M). Zydus Lifesciences Limited processed 64 shipments to 5 destination countries.
What Salmeterol Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FORAIR 125 INHALER CFC FREE (SALMETEROL | $97.7K | 9 |
| FORAIR 250 INHALER CFC FREE (SALMETEROL | $89.1K | 6 |
| FORAIR 250 (SALMETEROL & FLUTICASONE PRO | $87.5K | 4 |
| FORAIR 250 INHALER (SALMETEROL AND FLUTICASONE PROPIONATE INHALATION) 1X120MDI | $59.9K | 2 |
| FORAIR 250 INHALER CFC FREE (SALMETEROLAND FLUTICASONE PROPIONATE INHALER) 1X120MDI UNDER LUT NO.AD240323012473N DT.14.NOS | $47.2K | 2 |
| FORAIR 125 (SALMETEROL & FLUTICASONE PRO | $43.3K | 2 |
| FORAIR 250 INHALER CFC FREE(SALMETEROL AND FLUTICASONE PROPIONATE INHALER)(1X120MDI) | $41.1K | 2 |
| FORAIR 250 INHALER CFC FREE, PHIL SALMETEROL XINAFOATE AND FLUTICASONE PROPIONATE IN (1X120MDI) | $40.3K | 1 |
| SALMETEROL 25MCG + FLUTICASONE PROPIONAT | $39.7K | 2 |
| FORAIR 125 HFA INHALER 120MDI SALMETEROL FLUTICASONE PROPIONATE INHALATION IP25MCG 125MCG 1X120MDI UNDER LUT NO | $33.8K | 1 |
Zydus Lifesciences Limited exports 40 distinct Salmeterol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FORAIR 125 INHALER CFC FREE (SALMETEROL with 9 shipments worth $97.7K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Zydus Lifesciences Limited Compare to Nearest Salmeterol Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | HETERO LABS LIMITED | $6.4M | 139 | 4 | $46.0K |
| 3 | MEDISPRAY LABORATORIES PRIVATE LIMITED | $1.1M | 22 | 1 | $50.0K |
| 4 | ZYDUS LIFESCIENCES LIMITED ★ | $1.1M | 64 | 5 | $17.1K |
| 5 | VAMSI PHARMA PRIVATE LIMITED | $900.0K | 18 | 2 | $50.0K |
| 6 | SAVA HEALTHCARE LIMITED | $614.7K | 586 | 4 | $1.0K |
Zydus Lifesciences Limited ranks #4 among 148 Indian Salmeterol exporters. Average shipment value of $17.1K compared to the market average of $465.4K. The closest competitors by value are HETERO LABS LIMITED and MEDISPRAY LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Salmeterol Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,431 | 20.4% |
| SAHAR AIR | 1,278 | 18.2% |
| DELHI AIR | 1,169 | 16.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 633 | 9.0% |
| NHAVA SHEVA SEA (INNSA1) | 405 | 5.8% |
| Delhi Air | 309 | 4.4% |
| Bombay Air | 228 | 3.3% |
| JNPT/ NHAVA SHEVA SEA | 191 | 2.7% |
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Salmeterol Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Salmeterol, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salmeterol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salmeterol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 64 individual customs records matching Zydus Lifesciences Limited exporting Salmeterol, covering 40 formulations to 8 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 90+ countries, 370+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salmeterol Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Salmeterol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Salmeterol Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salmeterol. For current shipment-level data, contact TransData Nexus.